Zdrowie i gospodarka · 27/10/1994

Advisory Committee Meeting; Amendment of Notice

The Food and Drug Administration (FDA) is announcing an amendment to the notice of the joint meeting of the Nonprescription Drugs and the Pulmonary-Allergy Drugs Advisory Committees, which was announced in the Federal Register of July 7, 1994 (59 FR 34847). The amendment is being made to add an additional topic to the agenda of the open session and to add a closed session for the Nonprescription Drugs Advisory Committee. There are no other changes. This amendment will be announced at the beginning of the open portion of the meeting.